Vivek Uttam
Bathinda, PB 151401, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Overcoming immune resistance through tumor microenvironment reprogramming: Emerging immunotherapeutic strategies and translational advances.
Journal: Biochemical pharmacology
Published: June 07, 2026
Long non-coding RNAs as regulators of immune signaling pathways in esophageal cancer.
Journal: Biochemical pharmacology
Published: January 05, 2026
Comparative clinical significance of HPV DNA, HPV E6/E7 mRNA, and p16INK4a in cervical cancer among Indian and USA populations: a meta-analysis and systematic review.
Journal: Scientific reports
Published: October 05, 2025
Comprehensive review on outcomes from Phase 3 clinical trials of drugs in multiple myeloma.
Journal: Cancer treatment and research communications
Published: September 30, 2025
Clinical Significance of LINC00261 in the Pathogenesis of Pancreatic, Colorectal, Hepatocellular, and Gallbladder Cancer.
Journal: Diseases (Basel, Switzerland)
Published: January 19, 2025
G-Protein-Coupled Estrogen Receptor 1 (GPER1) Activation Mitigates Haloperidol-Induced Neurotoxicity in SHSY-5Y Cells and Improves Motor Functions in Adult Zebrafish.
Journal: Neurochemical research
Published: December 17, 2024
CAR-macrophages: tailoring cancer immunotherapy.
Journal: Frontiers in immunology
Published: November 22, 2024
LncRNAs SOX2-OT and NEAT1 act as a potential biomarker for esophageal squamous cell carcinoma.
Journal: Discover oncology
Published: March 20, 2024
The miRNA and PD-1/PD-L1 signaling axis: an arsenal of immunotherapeutic targets against lung cancer.
Journal: Cell death discovery
Published: March 10, 2024
Antitumor activity of genetically engineered NK-cells in non-hematological solid tumor: a comprehensive review.
Journal: Frontiers in immunology
Published: February 23, 2024
Last Updated: 09/26/2026